Implantable Cardiac Pacemaker Market -
Global Forecast to 2026
Implantable cardiac pacemaker is a small device implanted in the chest or abdomen for the
treatment of abnormal heart rhythms, arrhythmia, heart block, and atrial fibrillation. Implantable
cardiac pacemaker is evolved from battery-powered transistorized wearable pacemakers to current
leadless pacemaker, an entire pacemaker which is placed within cardiac chambers. Cardiac
pacemakers are used to treat abnormal electrical signaling in the heart, which causes arrhythmias.
Implantable cardiac pacemaker use low-energy electrical signals to speed up the slow heartbeat,
help to control an abnormal and fast heart rhythm, and prevents long QT syndrome, a disorder of
the heart’s electrical activity, which causes sudden, uncontrollable, and dangerous arrhythmias.
Download PDF Brochure Of This Research Report @
https://www.coherentmarketinsights.com/insight/request-pdf/1663
Market Dynamics
Market players are engaged in developing novel pacemakers with ability to control the abnormal
heart rhythm, monitor and record patient’s heart's electrical activity, blood temperature, and
breathing rate. Technological advances in the field of implantable cardiac pacemakers along with
increasing prevalence of cardiovascular disease is projected to drive the growth of implantable
cardiac pacemaker market over the forecast period.
Introduction of Advanced Pacemaker Technologies is Expected to Drive Growth of the
Implantable Cardiac Pacemaker Market
Adoption of advanced technologies in cardiac pacemakers such as MRI safe-pacemakers,
pacemakers with improved battery life, delay the progression of persistent Atrial Fibrillation (AF) in
patients suffering from bradycardia and wireless automated technologies. This advancements are